Zeynep Tamay
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Zeynep Tamay has a total of 191 co-authors. Here are the top co-authors by number of shared publications:
- Nermin Güler
Istanbul Universitesi
12 shared publications - Ayse Suleyman
Division of Pediatric Allergy and Immunology, Department of Pediatrics, Istanbul Faculty of Medicine, Istanbul University, Istanbul 34093, Türkiye
11 shared publications - Esra Yucel
Cerrahpasa Faculty of Medicine, Department of Pediatric Allergy and Immunology Istanbul University‐Cerrahpasa Istanbul Turkiye
11 shared publications Nermin Guler
11 shared publications- Cevdet Ozdemir
Department of Pediatric Basic Sciences, Institute of Child Health Istanbul University Istanbul Türkiye
10 shared publications Ulker Ones
Department of Pediatrics; Clinic of Dr. Ulker Ones; Istanbul Turkey
10 shared publications
Latest Publications
- Open Access
- 17 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (22) , 9006
Aeroallergen Sensitization Is Not a Stable Phenotype in Childhood: A Longitudinal Analysis
Background/Objectives: Aeroallergen sensitization can change with age and over time during childhood. We examined long-term trends, co-sensitization patterns, and changes in sensitization status within individual children, and assessed factors associated with progression to polysensitization. Methods: We analyzed 30,072 skin prick test records from 25,460 children evaluated for 32 aeroallergens at a tertiary pediatric allergy center over 15 years. Longitudinal transitions were assessed in a selected cohort of 2092 children retested as part of clinical care at least 2 calendar years apart. Predictors of sensitization transitions were examined using multivariable logistic regression. Results: Among 835 initially nonsensitized children, 34.5% became sensitized, and 67.7% of these were polysensitized at retesting. New sensitization increased from 28.8% after 2 to 3 years to 45.7% after 6 years or more. Monosensitization was particularly unstable: 41.7% progressed to polysensitization, 43.2% had no positive SPT result at follow-up, and only 15.1% remained monosensitized. In contrast, polysensitization persisted in 71.5% of initially polysensitized children. Initial house dust mite sensitization was associated with progression from mono- to polysensitization (adjusted odds ratio, 3.09; 95% CI, 1.57–6.07). Co-sensitization also became more strongly clustered over time, with all 21 pairwise allergen-group associations stronger during the pandemic and post-pandemic period. Conclusions: In this selected cohort of retested children, aeroallergen sensitization changed between the first and last assessments. Monosensitization usually did not persist, whereas polysensitization was more stable. Initial house dust mite sensitization was associated with approximately threefold higher odds of progression to polysensitization. Co-sensitization associations strengthened during the pandemic and post-pandemic period, particularly among indoor allergens. These transition rates should not be interpreted as estimates of population natural history.
- 17 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (22) , 9006
Open AccessAeroallergen Sensitization Is Not a Stable Phenotype in Childhood: A Longitudinal Analysis
Background/Objectives: Aeroallergen sensitization can change with age and over time during childhood. We examined long-term trends, co-sensitization patterns, and changes in sensitization status within individual children, and assessed factors associated with progression to polysensitization. Methods: We analyzed 30,072 skin prick test records from 25,460 children evaluated for 32 aeroallergens at a tertiary pediatric allergy center over 15 years. Longitudinal transitions were assessed in a selected cohort of 2092 children retested as part of clinical care at least 2 calendar years apart. Predictors of sensitization transitions were examined using multivariable logistic regression. Results: Among 835 initially nonsensitized children, 34.5% became sensitized, and 67.7% of these were polysensitized at retesting. New sensitization increased from 28.8% after 2 to 3 years to 45.7% after 6 years or more. Monosensitization was particularly unstable: 41.7% progressed to polysensitization, 43.2% had no positive SPT result at follow-up, and only 15.1% remained monosensitized. In contrast, polysensitization persisted in 71.5% of initially polysensitized children. Initial house dust mite sensitization was associated with progression from mono- to polysensitization (adjusted odds ratio, 3.09; 95% CI, 1.57–6.07). Co-sensitization also became more strongly clustered over time, with all 21 pairwise allergen-group associations stronger during the pandemic and post-pandemic period. Conclusions: In this selected cohort of retested children, aeroallergen sensitization changed between the first and last assessments. Monosensitization usually did not persist, whereas polysensitization was more stable. Initial house dust mite sensitization was associated with approximately threefold higher odds of progression to polysensitization. Co-sensitization associations strengthened during the pandemic and post-pandemic period, particularly among indoor allergens. These transition rates should not be interpreted as estimates of population natural history.
- 16 November 2026
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 37 (11)
Reply to Ramica Sharma
- 16 November 2026
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 37 (11)
Reply to Ramica Sharma
- 25 January 2025
- Published by Taylor & Francis in Journal of Asthma
- Vol. 62 (6) , 1013-1019
The assessment of exhaled nitric oxide in patients with obesity and asthma before and after exercise
It is well known that children who suffer from obesity and asthma may also have exercise-induced bronchospasm. Exhaled nitric oxide is an indicator of airway inflammation, and could be affected by exercise. This study looked at how exercise, which is a typical cause of acute airway obstruction, affects the levels of FeNO and spirometric parameters in obese and asthmatic children. Seventy children between the ages of 6 and 18 were divided into four groups: healthy children, obese children with asthma, obese children without asthma, and normal-weight asthmatic children. FeNO and spirometric parameters were assessed before and after exercise. Their heart rate was raised to 160-170 beats per minute by walking on a flat surface. The highest mean FeNO was seen in the asthmatic-obese group, while the lowest mean FeNO was found in the healthy group. MEF25-75 increased with exercise in the obese non-asthmatic group. FEV1/FVC was the lowest in the asthmatic-obese group. FeNO and FEV1/FVC have a strong association with asthma. The highest values of FeNO found in asthma-obesity combined. It was seen that obesity increased inflammation but exercise did not affect FeNO values. FeNO and FEV1 values were found to be higher in obese patients with and without asthma than normal weight and overweight asthmatics and non-asthmatics.
- 25 January 2025
- Published by Taylor & Francis in Journal of Asthma
- Vol. 62 (6) , 1013-1019
The assessment of exhaled nitric oxide in patients with obesity and asthma before and after exercise
It is well known that children who suffer from obesity and asthma may also have exercise-induced bronchospasm. Exhaled nitric oxide is an indicator of airway inflammation, and could be affected by exercise. This study looked at how exercise, which is a typical cause of acute airway obstruction, affects the levels of FeNO and spirometric parameters in obese and asthmatic children. Seventy children between the ages of 6 and 18 were divided into four groups: healthy children, obese children with asthma, obese children without asthma, and normal-weight asthmatic children. FeNO and spirometric parameters were assessed before and after exercise. Their heart rate was raised to 160-170 beats per minute by walking on a flat surface. The highest mean FeNO was seen in the asthmatic-obese group, while the lowest mean FeNO was found in the healthy group. MEF25-75 increased with exercise in the obese non-asthmatic group. FEV1/FVC was the lowest in the asthmatic-obese group. FeNO and FEV1/FVC have a strong association with asthma. The highest values of FeNO found in asthma-obesity combined. It was seen that obesity increased inflammation but exercise did not affect FeNO values. FeNO and FEV1 values were found to be higher in obese patients with and without asthma than normal weight and overweight asthmatics and non-asthmatics.
- 28 November 2024
- Published by Wiley in Pediatric Pulmonology
- Vol. 60 (1) , e27422
Different Aspects of COVID‐19: “Stay at Home” Increased Cat and Mite Sensitivity in Preschool Children
Background: Indoor allergen exposure and senitization is expected to increase significantly during the COVID‐19 pandemic. The aim of this study was to assess the impact of this altered allergen exposure on allergen sensitivity patterns in children with asthma. Methods: Demographic data, clinical characteristics, and laboratory findings of asthmatic children aged 5 years and younger were assessed May 2019 to May 2020, 1 year after the start of lockdown measures. Those asthmatic children were compared with age‐ and sex‐matched asthmatic peers assessed before the pandemic. Group I included asthmatic children who underwent skin testing within 12 months of the start of the lockdown ( n = 112), while Group II included asthmatic children whose skin testing was done before the lockdown ( n = 224). Results: A total of 336 preschool children diagnosed with asthma were evaluated. House dust mite (HDM) and animal dander (cat, dog) senitization rates were significantly higher in Group I than in Group II (66.1% vs. 42.9%; OR: 2.5, 95% CI: 1.6–4.1, p < 0.001 and 8.0% vs. 1.3%; OR: 6.4, CI: 1.7–24.2, p = 0.006, respectively). However, the number of asthma attacks requiring systemic corticosteroid treatment was higher in Group I than in Group II ( p = 0.001). The duration of lockdown emerged as a significant risk factor for HDM senitization ( p < 0.001, OR: 2.6, 95% CI: 1.6–4.1) and animal allergen senitization ( p = 0.006, OR: 6.4, 95% CI: 1.7–27.3). Conclusion: During the pandemic, senitization to indoor allergens, including HDM and animal dander, increased significantly in asthmatic children. This may be attributed to changes in lifestyle, increased time spent indoors and increased pet ownership.
- 28 November 2024
- Published by Wiley in Pediatric Pulmonology
- Vol. 60 (1) , e27422
Different Aspects of COVID‐19: “Stay at Home” Increased Cat and Mite Sensitivity in Preschool Children
Background: Indoor allergen exposure and senitization is expected to increase significantly during the COVID‐19 pandemic. The aim of this study was to assess the impact of this altered allergen exposure on allergen sensitivity patterns in children with asthma. Methods: Demographic data, clinical characteristics, and laboratory findings of asthmatic children aged 5 years and younger were assessed May 2019 to May 2020, 1 year after the start of lockdown measures. Those asthmatic children were compared with age‐ and sex‐matched asthmatic peers assessed before the pandemic. Group I included asthmatic children who underwent skin testing within 12 months of the start of the lockdown ( n = 112), while Group II included asthmatic children whose skin testing was done before the lockdown ( n = 224). Results: A total of 336 preschool children diagnosed with asthma were evaluated. House dust mite (HDM) and animal dander (cat, dog) senitization rates were significantly higher in Group I than in Group II (66.1% vs. 42.9%; OR: 2.5, 95% CI: 1.6–4.1, p < 0.001 and 8.0% vs. 1.3%; OR: 6.4, CI: 1.7–24.2, p = 0.006, respectively). However, the number of asthma attacks requiring systemic corticosteroid treatment was higher in Group I than in Group II ( p = 0.001). The duration of lockdown emerged as a significant risk factor for HDM senitization ( p < 0.001, OR: 2.6, 95% CI: 1.6–4.1) and animal allergen senitization ( p = 0.006, OR: 6.4, 95% CI: 1.7–27.3). Conclusion: During the pandemic, senitization to indoor allergens, including HDM and animal dander, increased significantly in asthmatic children. This may be attributed to changes in lifestyle, increased time spent indoors and increased pet ownership.
- Open Access
- 6 September 2024
- Published by Galenos Yayinevi in Balkan Medical Journal
- Vol. 41 (5) , 387-395
Comparison of Immune Checkpoint Molecule Expression in Different Years of House Dust Mite Subcutaneous Immunotherapy on CD4+ T and Treg Cells in Children with Allergic Rhinitis
Allergen-specific immunotherapy, a unique inducer of tolerance, may result in T cell exhaution. To investigate how the duration of house dust mite (HDM) subcutaneous immunotherapy (SCIT) affects the expression of major immune checkpoint (ICP) molecules on the surface of CD4+ T-helper and regulatory T (Treg) cells. Cross-sectional study. We enrolled 28 children with HDM-induced allergic rhinitis (AR) and six controls. The study participants were divided into six groups: one group each of patients in their first, second, and third years of HDM-SCIT; one group each comprising those in the first year following HDM-SCIT and those on pharmacotherapy; and the control group. The expression of ICPs on CD4+ T and Treg cells was determined using flow cytometry, and plasma levels of soluble ICPs were estimated by ELISA. Our results revealed a significant increase in the expression of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and lymphocyte activation gene 3 (LAG-3) on CD4+ T cells during the second and third years of SCIT, respectively. Additionally, a strong correlation was observed between the expression of CTLA-4 and T cell immunoglobulin and mucin domain containing molecule-3 in CD4+ T cells. Furthermore, we observed a significant correlation between the expressions of programmed cell death protein-1, CTLA-4, T cell Immunoreceptor with Immunoglobulin and Immunoreceptor Tyrosine-Based Inhibitory Motif domain, and LAG-3 on both CD4+ T and Treg cells. A robust correlation was observed between the plasma levels of soluble ICPs. HDM-SCIT induces CD4+ T cell exhaution, which may contribute to tolerance induction in children with AR.
- 6 September 2024
- Published by Galenos Yayinevi in Balkan Medical Journal
- Vol. 41 (5) , 387-395
Open AccessComparison of Immune Checkpoint Molecule Expression in Different Years of House Dust Mite Subcutaneous Immunotherapy on CD4+ T and Treg Cells in Children with Allergic Rhinitis
Allergen-specific immunotherapy, a unique inducer of tolerance, may result in T cell exhaution. To investigate how the duration of house dust mite (HDM) subcutaneous immunotherapy (SCIT) affects the expression of major immune checkpoint (ICP) molecules on the surface of CD4+ T-helper and regulatory T (Treg) cells. Cross-sectional study. We enrolled 28 children with HDM-induced allergic rhinitis (AR) and six controls. The study participants were divided into six groups: one group each of patients in their first, second, and third years of HDM-SCIT; one group each comprising those in the first year following HDM-SCIT and those on pharmacotherapy; and the control group. The expression of ICPs on CD4+ T and Treg cells was determined using flow cytometry, and plasma levels of soluble ICPs were estimated by ELISA. Our results revealed a significant increase in the expression of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and lymphocyte activation gene 3 (LAG-3) on CD4+ T cells during the second and third years of SCIT, respectively. Additionally, a strong correlation was observed between the expression of CTLA-4 and T cell immunoglobulin and mucin domain containing molecule-3 in CD4+ T cells. Furthermore, we observed a significant correlation between the expressions of programmed cell death protein-1, CTLA-4, T cell Immunoreceptor with Immunoglobulin and Immunoreceptor Tyrosine-Based Inhibitory Motif domain, and LAG-3 on both CD4+ T and Treg cells. A robust correlation was observed between the plasma levels of soluble ICPs. HDM-SCIT induces CD4+ T cell exhaution, which may contribute to tolerance induction in children with AR.
- Open Access
- 20 September 2023
- Published by S. Karger AG in International Archives of Allergy and Immunology
- Vol. 185 (1) , 56-62
Drug Allergy in Children: Adverse Reactions after Skin Testing
Introduction: Skin tests are one of the most widely used diagnostic tools for suspected drug allergies in children. Studies on systemic reactions occurring during skin testing with allergens have mostly been conducted in pediatric and adult patient groups together. However, data on adverse reactions including allergic reactions after drug skin tests in children are scarce. It is aimed to determine the adverse reactions after skin test in children with suspected drug allergy. Methods: Patients who underwent a drug skin test due to the suspicion of drug allergy between May 2017 and June 2020 were evaluated, retrospectively. Data about adverse reactions seen after skin testing at the testing area in the clinic were analyzed. Results: The study included 1,073 children (585 [54.5%] boys and 488 [45.5%] girls) with a median age of 7.5 years. A total of 12 (1.1%) reactions were detected after skin testing, and 4 (0.4%) of them were allergic reactions. Of the allergic reactions, three were anaphylaxis and one was urticaria. Two of the reactions (1 anaphylaxis and 1 urticaria) were detected after the skin prick test and the remaining 2 were detected after intradermal test. Three of the nonallergic reactions were considered as vasovagal reactions and seven were considered as nonspecific and anxiety-related reactions. Conclusion: Although drug skin tests were generally well-tolerated and adverse reactions were rare, severe allergic reactions including anaphylaxis may ensue. Skin tests should be necessarily performed in clinical settings in experienced centers.
- 20 September 2023
- Published by S. Karger AG in International Archives of Allergy and Immunology
- Vol. 185 (1) , 56-62
Open AccessDrug Allergy in Children: Adverse Reactions after Skin Testing
Introduction: Skin tests are one of the most widely used diagnostic tools for suspected drug allergies in children. Studies on systemic reactions occurring during skin testing with allergens have mostly been conducted in pediatric and adult patient groups together. However, data on adverse reactions including allergic reactions after drug skin tests in children are scarce. It is aimed to determine the adverse reactions after skin test in children with suspected drug allergy. Methods: Patients who underwent a drug skin test due to the suspicion of drug allergy between May 2017 and June 2020 were evaluated, retrospectively. Data about adverse reactions seen after skin testing at the testing area in the clinic were analyzed. Results: The study included 1,073 children (585 [54.5%] boys and 488 [45.5%] girls) with a median age of 7.5 years. A total of 12 (1.1%) reactions were detected after skin testing, and 4 (0.4%) of them were allergic reactions. Of the allergic reactions, three were anaphylaxis and one was urticaria. Two of the reactions (1 anaphylaxis and 1 urticaria) were detected after the skin prick test and the remaining 2 were detected after intradermal test. Three of the nonallergic reactions were considered as vasovagal reactions and seven were considered as nonspecific and anxiety-related reactions. Conclusion: Although drug skin tests were generally well-tolerated and adverse reactions were rare, severe allergic reactions including anaphylaxis may ensue. Skin tests should be necessarily performed in clinical settings in experienced centers.
- 22 July 2022
- Published by Wiley in Pediatric Pulmonology
- Vol. 57 (11) , 2622-2628
Antibiotic allergy in children with cystic fibrosis: A retrospective case–control study
Antibiotic allergy is a big problem that may affect the treatment and life quality of patients with cystic fibrosis (CF).Aim: To evaluate predictive factors for confirmed antibiotic hypersensitivity in children with CF.Methods: In this case–controlled study, we examined 15 patients with CF who had been confirmed with antibiotic allergy. Additionally, we included a control group of age‐ and gender‐matched 45 CF patients with no antibiotic allergy. The diagnosis of antibiotic allergy was confirmed in the presence of a compatible history and a positive response in the drug skin test or provocation test. Multiple drug hypersensitivity was classified according to the temporal relationship of antibiotics: (i) distant, (ii) simultaneous, and (iii) sequential. The data were analyzed by conditional logistic regression.Results: β‐lactam allergy was confirmed in eight patients (ceftazidime n = 5, piperacillin‐tazobactam n = 3) and non‐β‐lactam allergy was confirmed in two patients (ciprofloxacin n = 1, azithromycin n = 1). Additionally, multiple drug hypersensitivity in five patients (distant n = 4, sequential n = 1), among whom two patients showed hypersensitivity against ceftazidime/piperacillin‐tazobactam+ ciprofloxacin/levofloxacin, two patients showed hypersensitivity against ceftazidime+ ciprofloxacin n = 2, and one patient showed hypersensitivity against piperacillin‐tazobactam+ amikacin+ trimethoprim‐sulfamethoxazole. All patients (n = 13) with confirmed β‐lactam allergy were meropenem tolerant. Multivariate analysis indicated that immediate reactions (, p < 0.001) and allergic evaluation in the first six months after the reaction (p = 0.036) were significant risk factors for the prediction of antibiotic hypersensitivity.Conclusion: Beta‐lactam antibiotic allergy is the most commonly confirmed drug allergy in children with CF. However, unlike normal children, ceftazidime and piperacillin‐tazobactam account for the majority.
- 22 July 2022
- Published by Wiley in Pediatric Pulmonology
- Vol. 57 (11) , 2622-2628
Antibiotic allergy in children with cystic fibrosis: A retrospective case–control study
Antibiotic allergy is a big problem that may affect the treatment and life quality of patients with cystic fibrosis (CF).Aim: To evaluate predictive factors for confirmed antibiotic hypersensitivity in children with CF.Methods: In this case–controlled study, we examined 15 patients with CF who had been confirmed with antibiotic allergy. Additionally, we included a control group of age‐ and gender‐matched 45 CF patients with no antibiotic allergy. The diagnosis of antibiotic allergy was confirmed in the presence of a compatible history and a positive response in the drug skin test or provocation test. Multiple drug hypersensitivity was classified according to the temporal relationship of antibiotics: (i) distant, (ii) simultaneous, and (iii) sequential. The data were analyzed by conditional logistic regression.Results: β‐lactam allergy was confirmed in eight patients (ceftazidime n = 5, piperacillin‐tazobactam n = 3) and non‐β‐lactam allergy was confirmed in two patients (ciprofloxacin n = 1, azithromycin n = 1). Additionally, multiple drug hypersensitivity in five patients (distant n = 4, sequential n = 1), among whom two patients showed hypersensitivity against ceftazidime/piperacillin‐tazobactam+ ciprofloxacin/levofloxacin, two patients showed hypersensitivity against ceftazidime+ ciprofloxacin n = 2, and one patient showed hypersensitivity against piperacillin‐tazobactam+ amikacin+ trimethoprim‐sulfamethoxazole. All patients (n = 13) with confirmed β‐lactam allergy were meropenem tolerant. Multivariate analysis indicated that immediate reactions (, p < 0.001) and allergic evaluation in the first six months after the reaction (p = 0.036) were significant risk factors for the prediction of antibiotic hypersensitivity.Conclusion: Beta‐lactam antibiotic allergy is the most commonly confirmed drug allergy in children with CF. However, unlike normal children, ceftazidime and piperacillin‐tazobactam account for the majority.
- Open Access
- 1 July 2022
- Published by Codon Publications in Allergologia et Immunopathologia
- Vol. 50 (4) , 97-104
COmparisoN of TastES of Available NutriTional integrated or non-integrated formulas for infants older than 1 year of age with cow’s milk allergy: A multicenter, prospective, single blind, cross-sectional observational clinical study (CONTEST Study)
Palatability of the infant formulas lacking cow milk protein formulas is reported by parents to be an important drawback. The purpose of this study is to examine decisions made by mothers of infants having cow milk protein allergy, and physicians concerning the palatability of unflavored extensively hydrolyzed formulas and amino acid-based formulas. We conducted a multi-center, randomized, single-blinded, observational taste study involving 149 pediatricians from gastroenterology and allergy subspecialties at 14 tertiary healthcare units from different regions of Turkey and involving 94 mothers of infants with cow milk protein allergy. Blinding was performed for seven formulas available in the market, which were the most commonly prescribed for feeding: four AAFs (Neocate-Numil®, Aptamil Pregomin AS-Numil®, Alfamino-Nestle®, Comidagen-Mamma®), one AAF specifically designed to address the growing nutritional and lifestyle needs of children >1 year (Neocate Junior-Numil®), 2 eHFs (Bebelac Pepti Junior-Numil®, Similac Alimentum-Abott®). Considering all three formula characteristics, Neocate junior-Numil® ranked as the number 1 product among seven products by mothers (63.8%) and physicians (69.8%). The ratings of mothers were significantly higher than the physicians (8.1 points and 6.1 points, respectively; p < 0.001). No difference was found in terms of taste, smell, and appearance for Neocate junior-Numil® between the mothers’ and physicians’ ratings. Since caregivers have responsibility for careful selection of replacement products for infants with cow milk protein allergy, it is noteworthy that increased awareness and confidence in the palatability characteristics of these products should motivate mothers and physicians to comply with replacement treatment in the long term.
- 1 July 2022
- Published by Codon Publications in Allergologia et Immunopathologia
- Vol. 50 (4) , 97-104
Open AccessCOmparisoN of TastES of Available NutriTional integrated or non-integrated formulas for infants older than 1 year of age with cow’s milk allergy: A multicenter, prospective, single blind, cross-sectional observational clinical study (CONTEST Study)
Palatability of the infant formulas lacking cow milk protein formulas is reported by parents to be an important drawback. The purpose of this study is to examine decisions made by mothers of infants having cow milk protein allergy, and physicians concerning the palatability of unflavored extensively hydrolyzed formulas and amino acid-based formulas. We conducted a multi-center, randomized, single-blinded, observational taste study involving 149 pediatricians from gastroenterology and allergy subspecialties at 14 tertiary healthcare units from different regions of Turkey and involving 94 mothers of infants with cow milk protein allergy. Blinding was performed for seven formulas available in the market, which were the most commonly prescribed for feeding: four AAFs (Neocate-Numil®, Aptamil Pregomin AS-Numil®, Alfamino-Nestle®, Comidagen-Mamma®), one AAF specifically designed to address the growing nutritional and lifestyle needs of children >1 year (Neocate Junior-Numil®), 2 eHFs (Bebelac Pepti Junior-Numil®, Similac Alimentum-Abott®). Considering all three formula characteristics, Neocate junior-Numil® ranked as the number 1 product among seven products by mothers (63.8%) and physicians (69.8%). The ratings of mothers were significantly higher than the physicians (8.1 points and 6.1 points, respectively; p < 0.001). No difference was found in terms of taste, smell, and appearance for Neocate junior-Numil® between the mothers’ and physicians’ ratings. Since caregivers have responsibility for careful selection of replacement products for infants with cow milk protein allergy, it is noteworthy that increased awareness and confidence in the palatability characteristics of these products should motivate mothers and physicians to comply with replacement treatment in the long term.
- 15 June 2022
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 33 (6)
Beware of α‐lactalbumin as a hidden allergen in measles, mumps, and rubella vaccine in the patients with cow's milk allergy
- 15 June 2022
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 33 (6)
Beware of α‐lactalbumin as a hidden allergen in measles, mumps, and rubella vaccine in the patients with cow's milk allergy
Comparing the levels of CTLA‐4‐dependent biological defects in patients with LRBA deficiency and CTLA‐4 insufficiency
Background: Lipopolysaccharide‐responsive beige‐like anchor protein (LRBA) deficiency and cytotoxic T‐lymphocyte protein‐4 (CTLA‐4) insufficiency are recently described disorders that present with susceptibility to infections, autoimmunity, and lymphoproliferation. Clinical and immunological comparisons of the diseases with long‐term follow‐up have not been previously reported. We sought to compare the clinical and laboratory manifestations of both diseases and investigate the role of flow cytometry in predicting the genetic defect in patients with LRBA deficiency and CTLA‐4 insufficiency.Methods: Patients were evaluated clinically with laboratory assessments for lymphocyte subsets, T follicular helper cells (TFH), LRBA expression, and expression of CD25, FOXP3, and CTLA4 in regulatory T cells (Tregs) at baseline and 16 h post‐stimulation.Results: LRBA‐deficient patients (n = 29) showed significantly early age of symptom onset, higher rates of pneumonia, autoimmunity, chronic diarrhea, and failure to thrive compared to CTLA‐4 insufficiency (n = 12). In total, 29 patients received abatacept with favorable responses and the overall survival probability was not different between transplanted versus non‐transplanted patients in LRBA deficiency. Meanwhile, higher probability of survival was observed in CTLA‐4‐insufficient patients (p = 0.04). The T‐cell subsets showed more deviation to memory cells in CTLA‐4‐insufficiency, accompanied by low percentages of Treg and dysregulated cTFH cells response in both diseases. Cumulative numbers of autoimmunities positively correlated with cTFH frequencies. Baseline CTLA‐4 expression was significantly diminished in LRBA deficiency and CTLA‐4 insufficiency, but significant induction in CTLA‐4 was observed after short‐term T‐cell stimulation in LRBA deficiency and controls, while this elevation was less in CTLA‐4 insufficiency, allowing to differentiate this disease from LRBA deficiency with high sensitivity (87.5%) and specificity (90%).Conclusion: This cohort provided detailed clinical and laboratory comparisons for LRBA deficiency and CTLA‐4 insufficiency. The flow cytometric approach is useful in predicting the defective gene; thus, targeted sequencing can be conducted to provide rapid diagnosis and treatment for these diseases impacting the CTLA‐4 pathway.
Comparing the levels of CTLA‐4‐dependent biological defects in patients with LRBA deficiency and CTLA‐4 insufficiency
Background: Lipopolysaccharide‐responsive beige‐like anchor protein (LRBA) deficiency and cytotoxic T‐lymphocyte protein‐4 (CTLA‐4) insufficiency are recently described disorders that present with susceptibility to infections, autoimmunity, and lymphoproliferation. Clinical and immunological comparisons of the diseases with long‐term follow‐up have not been previously reported. We sought to compare the clinical and laboratory manifestations of both diseases and investigate the role of flow cytometry in predicting the genetic defect in patients with LRBA deficiency and CTLA‐4 insufficiency.Methods: Patients were evaluated clinically with laboratory assessments for lymphocyte subsets, T follicular helper cells (TFH), LRBA expression, and expression of CD25, FOXP3, and CTLA4 in regulatory T cells (Tregs) at baseline and 16 h post‐stimulation.Results: LRBA‐deficient patients (n = 29) showed significantly early age of symptom onset, higher rates of pneumonia, autoimmunity, chronic diarrhea, and failure to thrive compared to CTLA‐4 insufficiency (n = 12). In total, 29 patients received abatacept with favorable responses and the overall survival probability was not different between transplanted versus non‐transplanted patients in LRBA deficiency. Meanwhile, higher probability of survival was observed in CTLA‐4‐insufficient patients (p = 0.04). The T‐cell subsets showed more deviation to memory cells in CTLA‐4‐insufficiency, accompanied by low percentages of Treg and dysregulated cTFH cells response in both diseases. Cumulative numbers of autoimmunities positively correlated with cTFH frequencies. Baseline CTLA‐4 expression was significantly diminished in LRBA deficiency and CTLA‐4 insufficiency, but significant induction in CTLA‐4 was observed after short‐term T‐cell stimulation in LRBA deficiency and controls, while this elevation was less in CTLA‐4 insufficiency, allowing to differentiate this disease from LRBA deficiency with high sensitivity (87.5%) and specificity (90%).Conclusion: This cohort provided detailed clinical and laboratory comparisons for LRBA deficiency and CTLA‐4 insufficiency. The flow cytometric approach is useful in predicting the defective gene; thus, targeted sequencing can be conducted to provide rapid diagnosis and treatment for these diseases impacting the CTLA‐4 pathway.